Boston Scientific Corporation (BSX) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-03 (expected, before the open). EPS estimate 0.78, revenue estimate 5.18B.
Over the last 12 reports the stock moved 5.4% on average (either way), rising 7 times and falling 5. EPS beat estimates 12 of 12 times; revenue 12 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-28 | 0.73 | 0.73 | +0.4% | 5.14B | 5.09B | -5.3% |
| Q2 FY2026 | 2026-07-29 | 0.86 | 0.84 | +3.0% | 5.44B | 5.38B | -0.1% |
| Q1 FY2026 | 2026-04-22 | 0.80 | 0.79 | +1.5% | 5.20B | 5.17B | +10.4% |
| Q4 FY2025 | 2026-02-04 | 0.80 | 0.78 | +2.4% | 5.29B | 5.28B | -15.3% |
| Q3 FY2025 | 2025-10-22 | 0.75 | 0.71 | +5.0% | 5.07B | 4.97B | +2.5% |
| Q2 FY2025 | 2025-07-23 | 0.75 | 0.73 | +3.4% | 5.06B | 4.89B | +3.0% |
| Q1 FY2025 | 2025-04-23 | 0.75 | 0.67 | +11.4% | 4.66B | 4.57B | +6.4% |
| Q4 FY2024 | 2025-02-05 | 0.70 | 0.66 | +6.5% | 4.56B | 4.42B | +1.4% |